Identification of a RUNX2 breakpoint due to a balanced chromosomal translocation between 6p21.1 and 18q23 in a patient with cleidocranial dysplasia
Clinical Pediatric Endocrinology · 2026
DOI: 10.1297/cpe.2026-0160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pediatric Endocrinology, 2026. Verfasst von Kosei Hasegawa und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hasegawa, K., Futagawa, N., Aya, K., Ago, Y., Miyahara, H., & Yoshimoto, J. (2026). Identification of a RUNX2 breakpoint due to a balanced chromosomal translocation between 6p21.1 and 18q23 in a patient with cleidocranial dysplasia. Clinical Pediatric Endocrinology. https://doi.org/10.1297/cpe.2026-0160
Vancouver
Hasegawa K, Futagawa N, Aya K, Ago Y, Miyahara H, Yoshimoto J. Identification of a RUNX2 breakpoint due to a balanced chromosomal translocation between 6p21.1 and 18q23 in a patient with cleidocranial dysplasia. Clinical Pediatric Endocrinology. 2026. doi:10.1297/cpe.2026-0160
BibTeX
@article{Hasegawa2026,
author = {Hasegawa, Kosei and Futagawa, Natsuko and Aya, Koki and Ago, Yuko and Miyahara, Hiroyuki and Yoshimoto, Junko},
title = {Identification of a RUNX2 breakpoint due to a balanced chromosomal translocation between 6p21.1 and 18q23 in a patient with cleidocranial dysplasia},
journal = {Clinical Pediatric Endocrinology},
year = {2026},
doi = {10.1297/cpe.2026-0160}
}
EUVIMED